BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 29299981)

  • 21. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues.
    Bignotti E; Calza S; Tassi RA; Zanotti L; Bandiera E; Sartori E; Odicino FE; Ravaggi A; Todeschini P; Romani C
    J Cell Mol Med; 2016 Dec; 20(12):2341-2348. PubMed ID: 27419385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral leukocyte microRNAs as novel biomarkers for COPD.
    Wang R; Xu J; Liu H; Zhao Z
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1101-1112. PubMed ID: 28435243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection.
    Hamam R; Ali AM; Alsaleh KA; Kassem M; Alfayez M; Aldahmash A; Alajez NM
    Sci Rep; 2016 May; 6():25997. PubMed ID: 27180809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of microRNAs in basal cell carcinoma.
    Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
    Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis.
    Tan X; Qin W; Zhang L; Hang J; Li B; Zhang C; Wan J; Zhou F; Shao K; Sun Y; Wu J; Zhang X; Qiu B; Li N; Shi S; Feng X; Zhao S; Wang Z; Zhao X; Chen Z; Mitchelson K; Cheng J; Guo Y; He J
    Clin Cancer Res; 2011 Nov; 17(21):6802-11. PubMed ID: 21890451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum miR-638 Combined with Squamous Cell Carcinoma-Related Antigen as Potential Screening Biomarkers for Cervical Squamous Cell Carcinoma.
    Zheng S; Li R; Liang J; Wen Z; Huang X; Du X; Dong S; Zhu K; Chen X; Liu D; Wu J; Liu Y; Zou X; Wang Y; Li J; Zeng F; Feng L; Yang G; Jing C
    Genet Test Mol Biomarkers; 2020 Apr; 24(4):188-194. PubMed ID: 32216635
    [No Abstract]   [Full Text] [Related]  

  • 28. MicroRNA-142-5p induces cancer stem cell-like properties of cutaneous squamous cell carcinoma via inhibiting PTEN.
    Bai X; Zhou Y; Chen P; Yang M; Xu J
    J Cell Biochem; 2018 Feb; 119(2):2179-2188. PubMed ID: 28857248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
    J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA Expression Profiling in Adrenal Myelolipoma.
    Decmann A; Perge P; Nyíro G; Darvasi O; Likó I; Borka K; Micsik T; Tóth Z; Bancos I; Pezzani R; Iacobone M; Patócs A; Igaz P
    J Clin Endocrinol Metab; 2018 Sep; 103(9):3522-3530. PubMed ID: 29982598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-34c-5p is related to recurrence in laryngeal squamous cell carcinoma.
    Re M; Çeka A; Rubini C; Ferrante L; Zizzi A; Gioacchini FM; Tulli M; Spazzafumo L; Sellari-Franceschini S; Procopio AD; Olivieri F
    Laryngoscope; 2015 Sep; 125(9):E306-12. PubMed ID: 26153151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
    van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
    Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
    Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is genetically linked to vulvar squamous cell carcinoma.
    Pinto AP; Miron A; Yassin Y; Monte N; Woo TY; Mehra KK; Medeiros F; Crum CP
    Mod Pathol; 2010 Mar; 23(3):404-12. PubMed ID: 20062014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.
    Sand M; Skrygan M; Georgas D; Sand D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
    J Dermatol Sci; 2012 Dec; 68(3):119-26. PubMed ID: 23026055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity.
    Giricz O; Reynolds PA; Ramnauth A; Liu C; Wang T; Stead L; Childs G; Rohan T; Shapiro N; Fineberg S; Kenny PA; Loudig O
    J Pathol; 2012 Jan; 226(1):108-19. PubMed ID: 21953071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered Plasma MicroRNA Expression in Patients with Mitral Chordae Tendineae Rupture.
    Bulent Vatan M; Kalaycı Yigin A; Akdemir R; Tarik Agac M; Akif Cakar M; Aksoy M; Tatli E; Kilic H; Gunduz H; Guzel D; Karacan K
    J Heart Valve Dis; 2016 Sep; 25(5):580-588. PubMed ID: 28238240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).
    Joerger M; Baty F; Früh M; Droege C; Stahel RA; Betticher DC; von Moos R; Ochsenbein A; Pless M; Gautschi O; Rothschild S; Brauchli P; Klingbiel D; Zappa F; Brutsche M
    Lung Cancer; 2014 Aug; 85(2):306-13. PubMed ID: 24928469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.